about
The Role of Interleukin-17, Interleukin-23, and Transforming Growth Factor-β in Pregnancy Complicated by Placental Insufficiency.Programmed death-1 and its ligand are novel immunotolerant molecules expressed on leukemic B cells in chronic lymphocytic leukemiaPercentages of NKT cells in the tissues of patients with non-small cell lung cancer who underwent surgical treatment.Th17/IL-17A might play a protective role in chronic lymphocytic leukemia immunity.[Umbilical cord blood as a source of nerve and stem cells].Regulatory T lymphocytes and transforming growth factor beta in epithelial ovarian tumors-prognostic significance.Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patientsDanazol induces apoptosis and cytotoxicity of leukemic cells alone and in combination with purine nucleoside analogs in chronic lymphocytic leukemia.Association of variants in BAFF (rs9514828 and rs1041569) and BAFF-R (rs61756766) genes with the risk of chronic lymphocytic leukemia.Neutral endopeptidase (NEP) is differentially involved in biological activities and cell signaling of colon cancer cell lines derived from various stages of tumor development.Abnormal cytokine production by bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells.Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia.A brief review of clinical trials involving manipulation of invariant NKT cells as a promising approach in future cancer therapies.A modified method of insulin producing cells' generation from bone marrow-derived mesenchymal stem cellsTL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients.Analysis of peripheral blood immune cells after prophylactic immunization with HPV-16/18 ASO4-adjuvanted vaccine.Production of proangiogenic cytokines during thalidomide treatment of multiple myeloma.[NKT cells: their development, mechanisms and effects of action].Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia.Antioxidative and anti-inflammatory effects of repaglinide in plasma of diabetic animals.Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response.CD1d expression is higher in chronic lymphocytic leukemia patients with unfavorable prognosis.Imbalance in circulatory iNKT, Th17 and T regulatory cell frequencies in patients with B-cell non-Hodgkin's lymphoma.BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features.Expression of death receptor 3 on peripheral blood mononuclear cells differes in adult IBD patients and children with newly diagnosed IBD.Intracellular IL-4 and IFN-γ expression in iNKT cells from patients with chronic lymphocytic leukemia.Interleukin-6 and oxidative stress in plasma of alloxan-induced diabetic rabbits after pioglitazone treatment.Activity of MMP-2, MMP-8 and MMP-9 in serum as a marker of progression of alcoholic liver disease in people from Lublin Region, eastern Poland.The function of a novel immunophenotype candidate molecule PD-1 in chronic lymphocytic leukemia.Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia.Upper respiratory tract colonization by gram-negative rods in patients with chronic lymphocytic leukemia: analysis of risk factors.The Elevated Serum Level of IFN- in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord StimulationTLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.Evaluation of myeloid and lymphoid dendritic cells in peritoneal fluid in women with non-malignant ovarian tumorsTumor necrosis factor receptors (TNFRs) on T lymphocytes and soluble TNFRs in different clinical courses of sarcoidosisComparison of methods for determining zeta-chain associated protein - 70 (ZAP-70) expression in patients with B-cell chronic lymphocytic leukemia (B-CLL)Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depressionThe high frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia is diminished through treatment with thalidomidePeripheral blood and bone marrow TNF and TNF receptors in early and advanced stages of B-CLL in correlation with ZAP-70 protein and CD38 antigenThe significance of soluble HLA-G plasma levels as well as messenger HLA-G for B-cell chronic lymphocytic leukemia (B-CLL)
P50
Q33862263-EB5DEC32-4CE2-46EB-B135-E3AF45F2C163Q34245048-E5AEDCBF-1607-435C-8B49-8006B4688BA4Q34821857-D5AF1849-3952-47BC-86F5-3344F8EEAA7DQ35040785-5DD9F6CA-5128-4255-B85C-AAAC8E0C3A3AQ35817538-9E8BDCBB-A247-4218-B7A6-28B7C6DBEB2AQ35886225-D9B28BAC-2990-440B-9E47-F6235A4AAB64Q35929374-CF27FAC0-AA2E-4D7B-AF05-BAF5D98F014FQ36547670-239DC152-925D-4612-A6A9-71C9B40F26EFQ37396032-BAD372CF-A74B-47C0-9AA7-423801E3AA70Q37396073-1EA40977-C412-42E3-9C79-3EABCD200638Q37397839-C844E74B-850B-4FFC-A5CB-0CC852C0C671Q37678076-37509E88-C458-4A3C-A65D-213523F9FF43Q38634685-B76A96B4-A89D-4EE0-BF26-4462807C7305Q38939711-AE8E5DD8-584E-4140-9A8E-68C464DE25A9Q40837206-41746B18-4D7F-4108-AA80-864C9824A4F2Q41223808-C018D7E9-3DA3-40B5-9921-10862B63558EQ43985652-C3127924-963C-4E4F-952D-1CB8F051A2CAQ44623920-80E9056F-6AD7-4394-BFCF-883A7DD05AB6Q46013515-41B44863-845A-4CC3-BD76-4245CFE39E86Q46557164-02322074-1701-429B-BBAF-D04E9F3582D5Q46715841-D940B4C6-7E25-4D3A-84C9-EA1F65863152Q46728347-0EF05EF9-C57B-4990-AAC8-8EE094F7547BQ47131914-765AECBD-50BE-4519-837D-4E96BF46FC95Q47939939-9CBDCCDA-9CC9-4952-8379-342C02880CACQ48842674-CD96226D-9B7B-4FA3-B630-9FEBF888EF3BQ49428366-86490842-1A84-42AE-A2E8-412B0E57FFA3Q50773049-A229D6CF-FAEC-41D4-9290-7DD808480545Q50895641-39DCAD0E-7281-4854-86F9-C466A7937A20Q54290307-D48D1101-96C5-444C-A7A2-37B1F85ED031Q54656167-4174CD2E-0620-4AC1-8FF4-BF1F0C9AE8A5Q55119191-98A16E10-ACEC-4965-B265-4090B1FFBE9BQ61818026-2BFA34C1-A236-4E70-8C9F-804A92267FECQ64896109-249EF2E2-4FA3-4E1B-841A-590958B04A73Q79311857-B39AA21A-E63B-471C-9E07-48ED8FD9B1B3Q80062399-4EC357AE-DB34-498C-A23F-105735A95F38Q80103632-408C6792-44D8-464F-A811-945BFF4F29C3Q80207114-5230E4EC-FC45-4EE2-821B-E50272CE9ADFQ80685315-155953D5-516B-45EA-A6C1-1F66E7674CDAQ80735365-45E3ADB2-A322-415E-BE58-188F3552A28AQ81326655-9F18D62B-75B9-407C-B0A6-A9A1A542D629
P50
description
researcher ORCID ID = 0000-0003-2340-9442
@en
wetenschapper
@nl
name
Agnieszka Bojarska-Junak
@ast
Agnieszka Bojarska-Junak
@en
Agnieszka Bojarska-Junak
@es
Agnieszka Bojarska-Junak
@nl
type
label
Agnieszka Bojarska-Junak
@ast
Agnieszka Bojarska-Junak
@en
Agnieszka Bojarska-Junak
@es
Agnieszka Bojarska-Junak
@nl
prefLabel
Agnieszka Bojarska-Junak
@ast
Agnieszka Bojarska-Junak
@en
Agnieszka Bojarska-Junak
@es
Agnieszka Bojarska-Junak
@nl
P106
P1153
6602635968
P31
P496
0000-0003-2340-9442